Allurion Technologies Files 8-K: Material Agreement & Equity Sales

Ticker: ALURW · Form: 8-K · Filed: Jul 1, 2024 · CIK: 1964979

Sentiment: neutral

Topics: material-agreement, equity-sale, corporate-action

Related Tickers: ALUR

TL;DR

Allurion (ALUR) filed an 8-K detailing a material agreement and unregistered equity sales. Watch for dilution.

AI Summary

Allurion Technologies, Inc. announced on June 28, 2024, that it entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and amendments to its articles of incorporation or bylaws. This filing indicates significant corporate actions and potential equity dilution.

Why It Matters

This 8-K filing signals important corporate developments for Allurion Technologies, including a new material agreement and the issuance of equity, which could impact its financial structure and future operations.

Risk Assessment

Risk Level: medium — The filing involves unregistered sales of equity securities, which can lead to dilution and increased market volatility.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Allurion Technologies?

The filing states that Allurion Technologies, Inc. entered into a material definitive agreement on June 28, 2024, but the specific details of this agreement are not provided in the excerpt.

What type of equity securities were sold on an unregistered basis?

The filing mentions unregistered sales of equity securities, but the specific type and amount of securities are not detailed in the provided text.

Are there any changes to Allurion Technologies' articles of incorporation or bylaws?

Yes, the filing indicates that there were amendments to Allurion Technologies' articles of incorporation or bylaws.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on June 28, 2024.

What is the standard industrial classification for Allurion Technologies?

The standard industrial classification for Allurion Technologies is SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841].

Filing Stats: 2,307 words · 9 min read · ~8 pages · Grade level 12.9 · Accepted 2024-07-01 16:40:58

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 1.1 Underwriting Agreement, dated as of June 28, 2024, among Allurion Technologies, Inc., Jefferies LLC and TD Securities (USA) LLC, as representatives of the underwriters named therein. 3.1 Certificate of Designations of Preferences Rights and Limitations of Series A Non-Voting Convertible Preferred Stock. 4.1 Form of Public Warrant. 4.2 Form of Private Placement Warrant. 10.1 Subscription Agreement, dated as of June 28 2024, between Allurion Technologies, Inc. and the investors named therein. 99.1 Press Release dated June 28, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ALLURION TECHNOLOGIES, INC. Date: July 1, 2024 By: /s/ Brendan Gibbons Name: Brendan Gibbons Title: Chief Legal Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing